ihbg-10
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Feb 1, 2011 (NCT01272739)
Timeline
2010s
- Jan 1, 2011
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ihbg-10
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01272752 | Phase 2 | Apr 1, 2013 | Avera Health |
| NCT01272765 | Phase 2 | Mar 1, 2012 | Avera Health |
| NCT01272739 | Phase 2 | Feb 1, 2011 | Avera Health |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Avera Health | Academic/Hospital | 3 | 3 | 1 | 2011 |
1 organizations
Page 1 / 1